Therapy of melanoma with allogeneic melanoma lysates alone or with interferon-alfa.
Mitchell
Malcolm S
MS
Hudson-Webber Cancer Research Center, Karmanos Cancer Institute, 110 East Warren Avenue, Suite 740, Detroit, MI 48201, USA.
Darrah
Denise
D
Stevenson
Lucy
L
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003598:Cytoskeletal Proteins / Q000008:administration & dosage; D004338:Drug Combinations; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D008050:Lipid A / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D015337:Multicenter Studies as Topic; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D016019:Survival Analysis; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D003598:Cytoskeletal Proteins; D004338:Drug Combinations; D016898:Interferon-alpha; D008050:Lipid A; C112124:detox adjuvant